PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 94 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,000 | 0.0% | 18,200 | +4.0% | 0.00% | – |
| Q1 2017 | $11,000 | +175.0% | 17,500 | +45.8% | 0.00% | – |
| Q4 2016 | $4,000 | +300.0% | 12,000 | +500.0% | 0.00% | – |
| Q3 2016 | $1,000 | -75.0% | 2,000 | -80.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 10,000 | -18.0% | 0.00% | – |
| Q1 2016 | $5,000 | -82.8% | 12,200 | -51.6% | 0.00% | – |
| Q4 2015 | $29,000 | +1350.0% | 25,200 | +1045.5% | 0.00% | – |
| Q3 2015 | $2,000 | 0.0% | 2,200 | +46.7% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | -66.7% | 1,500 | -66.7% | 0.00% | – |
| Q3 2014 | $6,000 | -25.0% | 4,500 | 0.0% | 0.00% | – |
| Q2 2014 | $8,000 | -11.1% | 4,500 | 0.0% | 0.00% | – |
| Q1 2014 | $9,000 | +50.0% | 4,500 | +3.9% | 0.00% | – |
| Q4 2013 | $6,000 | 0.0% | 4,333 | 0.0% | 0.00% | – |
| Q3 2013 | $6,000 | 0.0% | 4,333 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 4,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |